Literature DB >> 11788337

Cyclooxygenase 2-mediated suppression of macrophage interleukin-12 production after thermal injury.

Martin G Schwacha1, Chun-Shiang Chung, Alfred Ayala, Kirby I Bland, Irshad H Chaudry.   

Abstract

Macrophage (Mphi) prostaglandin (PG)E(2) production has been implicated in immunosuppression and increased susceptibility to sepsis after thermal injury. Deficient interleukin (IL)-12 production has also been implicated in these postburn complications. The present study examined the relationship between Mphi cyclooxygenase (COX)-2 activity and IL-12 production after thermal injury. C57BL/6 female mice were subjected to a 25% total body surface area full-thickness burn. Mphi were isolated 7 days later, or the mice were subjected to sepsis by cecal ligation and puncture (CLP). IL-12 production by Mphi from injured mice was suppressed by >50%, whereas COX-2 expression and PGE(2) production were increased twofold. The COX-2 inhibitor NS-398 suppressed PGE(2) production and normalized IL-12 production in the injury group, whereas it had no effect on IL-10 production. Injured mice subjected to CLP had lower IL-12 plasma levels compared with sham-treated mice subjected to CLP. NS-398 treatment prevented the suppression in plasma IL-12 levels in the injury group. Thus elevated Mphi COX-2 activity, independent of IL-10, suppresses Mphi IL-12 production after thermal injury and may play an important role in the observed immunosuppression under such conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788337     DOI: 10.1152/ajpcell.00357.2001

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  9 in total

1.  Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses.

Authors:  A Naldini; L Aarden; A Pucci; C Bernini; F Carraro
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

2.  A study on biomarkers, cytokines, and growth factors in children with burn injuries.

Authors:  N M Abdel-Hafez; Y Saleh Hassan; T H El-Metwally
Journal:  Ann Burns Fire Disasters       Date:  2007-06-30

Review 3.  Trauma equals danger--damage control by the immune system.

Authors:  Veit M Stoecklein; Akinori Osuka; James A Lederer
Journal:  J Leukoc Biol       Date:  2012-05-31       Impact factor: 4.962

4.  Rescuing macrophage function following severe thermal injury.

Authors:  Jeremy L Herrmann
Journal:  J Surg Res       Date:  2009-05-14       Impact factor: 2.192

5.  Early expression of IL-10, IL-12, ARG1 and NOS2 genes in peripheral blood mononuclear cells synergistically correlate with patient outcome after burn injury.

Authors:  Cressida Mahung; Wesley H Stepp; Clayton Long; Madison Malfitano; Irmak Saklayici; Shannon M Wallet; Laura Y Zhou; Haibo Zhou; Bruce A Cairns; Robert Maile
Journal:  J Trauma Acute Care Surg       Date:  2022-03-30       Impact factor: 3.697

Review 6.  Perturbed mononuclear phagocyte system in severely burned and septic patients.

Authors:  Fangming Xiu; Marc G Jeschke
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

7.  Lipopolysaccharide desensitizes monocytes-macrophages to CD40 ligand stimulation.

Authors:  Anna Sinistro; Chiara Ciaprini; Silvia Natoli; Emanuele Sussarello; Francesca Calò Carducci; Cristiana Almerighi; Marcella Capozzi; Francesca Bolacchi; Giovanni Rocchi; Alberto Bergamini
Journal:  Immunology       Date:  2007-06-29       Impact factor: 7.397

Review 8.  Advancements in Regenerative Strategies Through the Continuum of Burn Care.

Authors:  Randolph Stone Ii; Shanmugasundaram Natesan; Christine J Kowalczewski; Lauren H Mangum; Nicholas E Clay; Ryan M Clohessy; Anders H Carlsson; David H Tassin; Rodney K Chan; Julie A Rizzo; Robert J Christy
Journal:  Front Pharmacol       Date:  2018-07-09       Impact factor: 5.810

9.  Scald Injury-Induced T Cell Dysfunction Can Be Mitigated by Gr1+ Cell Depletion and Blockage of CD47/CD172a Signaling.

Authors:  Nadine Beckmann; Franziska Huber; Marc Hanschen; Barbara St Pierre Schneider; Vanessa Nomellini; Charles C Caldwell
Journal:  Front Immunol       Date:  2020-05-08       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.